Literature DB >> 29927104

Affinity Maturation Drives Epitope Spreading and Generation of Proinflammatory Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis.

Serra E Elliott1, Sarah Kongpachith1, Nithya Lingampalli1, Julia Z Adamska1, Bryan J Cannon1, Rong Mao1, Lisa K Blum1, William H Robinson1.   

Abstract

OBJECTIVE: Rheumatoid arthritis (RA) is characterized by the presence of anti-citrullinated protein antibodies (ACPAs); nevertheless, the origin, specificity, and functional properties of ACPAs remain poorly understood. The aim of this study was to characterize the evolution of ACPAs by sequencing the plasmablast antibody repertoire at serial time points in patients with established RA.
METHODS: Blood samples were obtained at up to 4 serial time points from 8 individuals with established RA who were positive for ACPAs by the anti-cyclic citrullinated peptide test. CD19+CD3-IgD-CD14-CD20-CD27+CD38++ plasmablasts were isolated by single-cell sorting and costained with citrullinated peptide tetramers to identify ACPA-expressing plasmablasts. Cell-specific oligonucleotide barcodes were utilized, followed by large-scale sequencing and bioinformatics analysis, to obtain error-corrected, paired heavy- and light-chain antibody gene sequences for each B cell.
RESULTS: Bioinformatics analysis revealed 170 persistent plasmablast lineages in the RA blood, of which 19% included multiple isotypes. Among IgG- and IgA-expressing plasmablasts, significantly more IgA-expressing than IgG-expressing persistent lineages were observed (P < 0.01). Shared complementarity-determining region 3 sequence motifs were identified across subjects. A subset of the plasmablast lineages included members derived from later time points with divergent somatic hypermutations that encoded antibodies that bind an expanded set of citrullinated antigens. Furthermore, these recombinant, differentially mutated plasmablast antibodies formed immune complexes that stimulated higher macrophage production of tumor necrosis factor (TNF) compared to antibodies representing earlier time point-derived lineage members that were less mutated.
CONCLUSION: These findings demonstrate that established RA is characterized by a persistent IgA ACPA response that exhibits ongoing affinity maturation. This observation suggests the presence of a persistent mucosal antigen that continually promotes the production of IgA plasmablasts and their affinity maturation and epitope spreading, thus leading to the generation of ACPAs that bind additional citrullinated antigens and more potently stimulate macrophage production of TNF.
© 2018, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29927104      PMCID: PMC6261684          DOI: 10.1002/art.40587

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  44 in total

1.  Pathogenic human monoclonal antibody against desmoglein 3.

Authors:  Shih-Wei Yeh; Lisa A Cavacini; Kailash C Bhol; Mong-Shang Lin; Mukesh Kumar; Mark Duval; Marshall R Posner; A Razzaque Ahmed
Journal:  Clin Immunol       Date:  2006-04-25       Impact factor: 3.969

2.  VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans.

Authors:  Nitya Nair; Ningguo Feng; Lisa K Blum; Mrinmoy Sanyal; Siyuan Ding; Baoming Jiang; Adrish Sen; John M Morton; Xiao-Song He; William H Robinson; Harry B Greenberg
Journal:  Sci Transl Med       Date:  2017-06-21       Impact factor: 17.956

3.  Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data.

Authors:  Namita T Gupta; Jason A Vander Heiden; Mohamed Uduman; Daniel Gadala-Maria; Gur Yaari; Steven H Kleinstein
Journal:  Bioinformatics       Date:  2015-06-10       Impact factor: 6.937

4.  Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation.

Authors:  Felipe Andrade; Erika Darrah; Marjan Gucek; Robert N Cole; Antony Rosen; Xiaoming Zhu
Journal:  Arthritis Rheum       Date:  2010-06

5.  Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis.

Authors:  John D Isaacs; Stanley B Cohen; Paul Emery; Paul P Tak; Jianmei Wang; Guiyuan Lei; Sarah Williams; Preeti Lal; Simon J Read
Journal:  Ann Rheum Dis       Date:  2012-06-11       Impact factor: 19.103

6.  Associations of toll-like receptor (TLR)-4 single nucleotide polymorphisms and rheumatoid arthritis disease progression: an observational cohort study.

Authors:  Marshall L R Davis; Tricia D LeVan; Fang Yu; Harlan Sayles; Jeremy Sokolove; William Robinson; Kaleb Michaud; Geoffrey M Thiele; Ted R Mikuls
Journal:  Int Immunopharmacol       Date:  2015-01-05       Impact factor: 4.932

7.  Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis.

Authors:  Kristine A Kuhn; Liudmila Kulik; Beren Tomooka; Kristin J Braschler; William P Arend; William H Robinson; V Michael Holers
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 8.  Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis.

Authors:  Bryant R England; Geoffrey M Thiele; Ted R Mikuls
Journal:  Curr Opin Rheumatol       Date:  2017-01       Impact factor: 5.006

9.  Local Joint inflammation and histone citrullination in a murine model of the transition from preclinical autoimmunity to inflammatory arthritis.

Authors:  Dong Hyun Sohn; Christopher Rhodes; Kazuhiro Onuma; Xiaoyan Zhao; Orr Sharpe; Tal Gazitt; Rani Shiao; Justyna Fert-Bober; Danye Cheng; Lauren J Lahey; Heidi H Wong; Jennifer Van Eyk; William H Robinson; Jeremy Sokolove
Journal:  Arthritis Rheumatol       Date:  2015-11       Impact factor: 10.995

10.  Convergent antibody signatures in human dengue.

Authors:  Poornima Parameswaran; Yi Liu; Krishna M Roskin; Katherine K L Jackson; Vaishali P Dixit; Ji-Yeun Lee; Karen L Artiles; Simona Zompi; Maria José Vargas; Birgitte B Simen; Bozena Hanczaruk; Kim R McGowan; Muhammad A Tariq; Nader Pourmand; Daphne Koller; Angel Balmaseda; Scott D Boyd; Eva Harris; Andrew Z Fire
Journal:  Cell Host Microbe       Date:  2013-06-12       Impact factor: 21.023

View more
  29 in total

1.  Timing of Elevations of Autoantibody Isotypes Prior to Diagnosis of Rheumatoid Arthritis.

Authors:  Lindsay B Kelmenson; Brandie D Wagner; Bryan K McNair; Ashley Frazer-Abel; M Kristen Demoruelle; Dylan T Bergstedt; Marie L Feser; Laura K Moss; Mark C Parish; Elizabeth A Mewshaw; Ted R Mikuls; Jess D Edison; V Michael Holers; Kevin D Deane
Journal:  Arthritis Rheumatol       Date:  2019-12-26       Impact factor: 10.995

Review 2.  Individuals at risk of seropositive rheumatoid arthritis: the evolving story.

Authors:  S Rantapää Dahlqvist; F Andrade
Journal:  J Intern Med       Date:  2019-10-21       Impact factor: 8.989

3.  B cells in rheumatoid arthritis synovial tissues encode focused antibody repertoires that include antibodies that stimulate macrophage TNF-α production.

Authors:  Serra E Elliott; Sarah Kongpachith; Nithya Lingampalli; Julia Z Adamska; Bryan J Cannon; Lisa K Blum; Michelle S Bloom; Matthew Henkel; Mandy J McGeachy; Larry W Moreland; William H Robinson
Journal:  Clin Immunol       Date:  2020-02-05       Impact factor: 3.969

4.  Affinity Maturation of the Anti-Citrullinated Protein Antibody Paratope Drives Epitope Spreading and Polyreactivity in Rheumatoid Arthritis.

Authors:  Sarah Kongpachith; Nithya Lingampalli; Chia-Hsin Ju; Lisa K Blum; Daniel R Lu; Serra E Elliott; Rong Mao; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2019-02-27       Impact factor: 10.995

5.  Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.

Authors:  Erika Darrah; Ryan L Davis; Ashley M Curran; Pooja Naik; Ruiqiang Chen; Chan Hyun Na; Jon T Giles; Felipe Andrade
Journal:  Arthritis Rheumatol       Date:  2020-07-14       Impact factor: 10.995

Review 6.  Understanding and measuring human B-cell tolerance and its breakdown in autoimmune disease.

Authors:  Kevin S Cashman; Scott A Jenks; Matthew C Woodruff; Deepak Tomar; Christopher M Tipton; Christopher D Scharer; F Eun-Hyung Lee; Jeremy M Boss; Iñaki Sanz
Journal:  Immunol Rev       Date:  2019-11-22       Impact factor: 12.988

Review 7.  B cell checkpoints in autoimmune rheumatic diseases.

Authors:  Samuel J S Rubin; Michelle S Bloom; William H Robinson
Journal:  Nat Rev Rheumatol       Date:  2019-05       Impact factor: 20.543

Review 8.  Single-cell technologies - studying rheumatic diseases one cell at a time.

Authors:  Peggie Cheung; Purvesh Khatri; Paul J Utz; Alex J Kuo
Journal:  Nat Rev Rheumatol       Date:  2019-06       Impact factor: 20.543

9.  Neutralizing anti-IL-1 receptor antagonist autoantibodies induce inflammatory and fibrotic mediators in IgG4-related disease.

Authors:  Justin A Jarrell; Matthew C Baker; Cory A Perugino; Hang Liu; Michelle S Bloom; Takashi Maehara; Heidi H Wong; Tobias V Lanz; Julia Z Adamska; Sarah Kongpachith; Jeremy Sokolove; John H Stone; Shiv S Pillai; William H Robinson
Journal:  J Allergy Clin Immunol       Date:  2021-05-08       Impact factor: 10.793

10.  H and L Chain Affinity Maturation and/or Fab N-Glycosylation Influence Immunoreactivity toward Neutrophil Extracellular Trap Antigens in Rheumatoid Arthritis Synovial B Cell Clones.

Authors:  Elisa Corsiero; Emanuela Carlotti; Lucas Jagemann; Mauro Perretti; Costantino Pitzalis; Michele Bombardieri
Journal:  J Immunol       Date:  2020-03-27       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.